Treatment Options for Esophageal Submucosal Cancer, from the Viewpoint of Surgery Takashi Kamei 1 , Yusuke Taniyama 1 , Chiaki Sato 1 , Hiroshi Okamoto 1 , Kai Takaya 1 , Toshiaki Fukutomi 1 1Department of Surgery, Graduate School of Medicine, Tohoku University, Sendai, Japan Keyword: 胸腔鏡下食道手術 , 3領域リンパ節郭清 , 腹腔鏡下胃管作製 pp.1265-1271
Published Date 2020/9/25
DOI https://doi.org/10.11477/mf.1403202139
  • Abstract
  • Look Inside
  • Reference

 Thoracoscopic esophagectomy with three-field lymphadenectomy is a minimally invasive treatment that has been widely adopted, and it has a great advantage of not only removing carcinoma with a high level of certainty but also providing detailed pathological diagnosis. Although both surgery and dCRT(definitive chemoradiotherapy)are treatment options for submucosal esophageal cancer, if there is lymph node metastasis, that is, cStage II, surgery is recommended after neoadjuvant chemotherapy. Conversely, dCRT followed by an optional salvage treatment should be considered for cStage I cancer, from the viewpoint of esophageal preservation. Esophageal surgery in a specialized institute with experience is recommended because of the good prognosis.

Copyright © 2020, Igaku-Shoin Ltd. All rights reserved.


電子版ISSN 1882-1219 印刷版ISSN 0536-2180 医学書院